Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    7:30 AM – 8:30 AM Eastern Time
    MTP01A: Meet the Professor: Crystalline Arthritis
    Location: Room 155
    Seminar Presenter: Michael Toprover, MD – New York University Langone Health
    Crystal arthropathies
     CME 1 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I
    Crystal arthropathies
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0265: Performance of Two Gout Remission Definitions in a Two-Year Randomized Controlled Trial of Nurse-led Care
    Abstract Poster Presenter: Adwoa Dansoa Tabi-Amponsah, BSc (she/her/hers) – The University of Auckland
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0266: Analysis of Gout Remission Definitions in a Randomised Controlled Trial of Colchicine Prophylaxis for People with Gout Initiating Allopurinol
    Abstract Poster Presenter: Adwoa Dansoa Tabi-Amponsah, BSc (she/her/hers) – The University of Auckland
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0267: IL-17 Participates in the Pathogenesis of Chronic Gouty Arthritis
    Abstract Poster Presenter: Yun Zhang, associate professor – Peking Union Medical College Hospital (CAMS)
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0268: Weight Loss Induced by Anti-obesity Medications and Gout Among Overweight and Obesity Individuals: A Population-based Cohort Study
    Abstract Poster Presenter: Jie Wei, DrPH (she/her/hers) – Xiangya Hospital Central South University
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0269: Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease
    Abstract Poster Presenter: Yiling Zhang, MBChB – Auckland City Hospital
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0270: Longitudinal Patterns of C-Reactive Protein Values in Calcium Pyrophosphate Deposition (CPPD) Disease
    Abstract Poster Presenter: Muneet Gill, BS (she/her/hers) – Brigham & Women's Hospital
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0271: Intercritical Gout Represents a Systemic Inflammatory State
    Abstract Poster Presenter: Tanner Ourada, BS – University of Nebraska-Medical Center: College of Medicine
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0272: Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study
    Abstract Poster Presenter: Shay Brikman, MD (he/him/his) – Emek Medical Center
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0273: Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study
    Abstract Poster Presenter: Elizabeth Lopez, BS (she/her/hers) – University of Alabama at Birmingham Heersink School of Medicine
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0274: Cost-effectiveness of Low Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start-Low Go-Slow” Approach for Gout
    Abstract Poster Presenter: Lisa Stamp, PhD,FRACP – University of Otago, Christchurch
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0275: Targeting IRAK4 in Monosodium Urate Crystals Induced Inflammation
    Abstract Poster Presenter: Sadiq Umar, PhD – University of Illinois at Chicago
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0276: Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort
    Abstract Poster Presenter: Marlene Marte Furment, MD – Medical Affiliates of Cape Cod
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0277: Mesenchymal Stem Cells Derived from Human Bone Marrow Ameliorate Monosodium Urate Crystal-induced Inflammation
    Abstract Poster Presenter: Jennifer Lee, MD, PhD – Seoul st mary's hospital
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0278: Efficacy and Safety of Genakumab versus Compound Betamethasone in Gout: The GUARD-1 Study
    Abstract Poster Presenter: Yu Xue, PhD – Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0279: Macrophage Intracellular Fates of Monosodium Urate and Calcium Pyrophosphate Crystals: Phagocytosis, Exchanged/expulsion and Dissolution of Crystals
    Abstract Poster Presenter: Hang-Korng Ea, MD,PhD – Université Paris Cité, INSERM UMR 1132 BIOSCAR
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0280: Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform
    Abstract Poster Presenter: Mark Russell, MBChB – King’s College London
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0281: Intra-articular Treatment Combining Sustained Release Colchicine Encapsulated in Microspheres, and Ropivacaine, Is Effective in Inflammatory Arthritis in Rats
    Abstract Poster Presenter: Marie-Christophe Boissier, MD, PhD – University Sorbonne Paris Nord
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0282: Electronic Health Record-Based Calcium Pyrophosphate Deposition Disease Registry: A Feasibility Study
    Abstract Poster Presenter: Nils Bürgisser, MD (he/him/his) – Geneva University Hospital
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0283: Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model
    Abstract Poster Presenter: Dmitri Lissin, MD – Scilex Holding
    Crystal arthropathies
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0284: Identification of Calcium Pyrophosphate Deposition Using Ultrasonography in Patients with a Suspected Diagnosis of Seronegative Rheumatoid Arthritis
    Abstract Poster Presenter: Angelo Gaffo, MD,FACP – University of Alabama at Birmingham
    Crystal arthropathies
  • Saturday, Nov 16th
    11:30 AM – 12:30 PM Eastern Time
    MTP01B: Meet the Professor: Crystalline Arthritis
    Location: Room 155
    Seminar Presenter: Michael Pillinger, MD – New York University Grossman School of Medicine
    Seminar Presenter: Michael Toprover, MD – New York University Langone Health
    Crystal arthropathies
     CME 1 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II
    Crystal arthropathies
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1083: Comparison of a Handheld Ultrasound Device with Cart-Based Ultrasound for the Assessment of Gout Lesions in People with Established Gout
    Abstract Poster Presenter: Nicola Dalbeth, MD – University of Auckland
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1084: Osteoporosis and Osteopenia Diagnosed by Dual-Energy X-Ray Absorptiometry Are Not Increased in Patients with Gout
    Abstract Poster Presenter: Karla Miller, MD (she/her/hers) – University of Utah School of Medicine
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1085: Pharmacokinetics and Pharmacodynamics of Tigulixostat in Participants with Mild, Moderate, and Severe Renal Impairment
    Abstract Poster Presenter: Ashish Kumar, PharmD, MPH – LG Chem
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1086: Risk Factors Associated with Loss to Follow-up in a Prospective Gout Cohort
    Abstract Poster Presenter: HYUNSUE DO, MD – Kangwon national university hospital
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1087: Sex Differences in Clinical Features and Mortality in Gout: A Nationwide Retrospective Cohort Study
    Abstract Poster Presenter: HYUNSUE DO, MD – Kangwon national university hospital
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1088: Prospective Evaluation of Carotid Atherosclerosis, Urate Deposits and Inflammation After One Year of Treatment in Newly Diagnosed Gout
    Abstract Poster Presenter: Cristina Rodríguez Alvear, III, -None- – General University Hospital Dr. Balmis-ISABIAL
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1089: Endothelial Activation in Gout
    Abstract Poster Presenter: Michael Toprover, MD – New York University Langone Health
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1090: Hepatic Fibrosis Before and During Intensive Urate-lowering with Pegloticase in the Presence and Absence of Methotrexate Co-therapy
    Abstract Poster Presenter: Brian LaMoreaux, MD;MS – Amgen, Inc.
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1091: Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study
    Abstract Poster Presenter: Chamaya De Silva, MBChB – Health New Zealand
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1092: Chronic Kidney Disease Is Associated with Increased Glucose Uptake-associated Metabolic Activity of Visceral Adipose and Subcutaneous Adipose Tissue in Gout Patients
    Abstract Poster Presenter: Shunya Kaneshita, MPH – UCSD
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1093: Risk of Dementia in Patients with Gout: Potential Impact of Survival Bias
    Abstract Poster Presenter: Joshua F. Baker, MD, MS – University of Pennsylvania
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1094: Longitudinal Analysis of Serum Urate in Prediabetic Phase
    Abstract Poster Presenter: Javier Marrugo, MD – Brigham and Women's Hospital
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1095: The Incidence of Gout Among Individuals with Hyperuricemia over Time – an Insight from a Nationwide Cohort Study
    Abstract Poster Presenter: Shay Brikman, MD (he/him/his) – Emek Medical Center
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1096: Exploring Multi Factorial Model for the Prediction of Gout in Patients with Hyperuricemia
    Abstract Poster Presenter: Amir Bieber, MD, MBA (he/him/his) – Emek Medical Center, Clalit Health Services
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1097: CERT Score as a Potential Tool to Predict Cardiovascular Risk in Gout and Hyperuricemia
    Abstract Poster Presenter: Blanka Stiburkova, PhD,MMSc – Institute of Rheumatology
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1098: Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study
    Abstract Poster Presenter: Cesar Diaz-Torne, MD,PhD – Hospital de la Santa Creu i Sant Pau
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1099: Distinct Metabolomic Signatures of Insulinemia and Incident Gout Risk: A Prospective Cohort Study Among Women
    Abstract Poster Presenter: Sharan Rai, PhD – Massachusetts General Hospital/Harvard Medical School
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1100: Coronary Dual-Energy Computed Tomography for the Detection of Monosodium Urate Crystal Deposition in the Arteries of Individuals with and Without Gout (CORODECT): A Multi-Center Prospective Imaging Study
    Abstract Poster Presenter: Chio Yokose, MD;MSc (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1101: The Contemporary Prevalence of Comorbid Gout and Chronic Kidney Disease, Two Common Conditions with High Morbidity, in the US General Population
    Abstract Poster Presenter: Chio Yokose, MD;MSc (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1102: Risk of Mortality and Major Cardiovascular-Kidney Outcomes in Patients with Tophaceous versus Non-Tophaceous Gout
    Abstract Poster Presenter: Gregory Challener, MD – MGH
    Crystal arthropathies
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1103: The Role of Renal Dual-Energy CT in Exploring the Gouty Kidney: The RENODECT Study
    Abstract Poster Presenter: Tristan Pascart, MD,PhD (he/him/his) – Lille Catholic University
    Crystal arthropathies
  • Monday, Nov 18th
    9:00 AM – 10:00 AM Eastern Time
    18M07: Of Kings and Men: Education and Remission in Gout
    Location: Ballroom A
    Moderator: Nicola Dalbeth, MD – University of Auckland
    Moderator: Puja Khanna, MD, MPH (she/her/hers) – University of Michigan
    Crystal arthropathies
     CME 1 hours
  • Monday, Nov 18th
    9:00 AM – 9:30 AM Eastern Time
    Patient Education in Gout: How to Bridge the Gap
    Location: Ballroom A
    Speaker: N. Lawrence Edwards, MD – University of Florida College of Medicine
    Crystal arthropathies
  • Monday, Nov 18th
    9:30 AM – 10:00 AM Eastern Time
    Recent Advancements in Defining and Achieving Remission in Gout
    Location: Ballroom A
    Speaker: Angelo Gaffo, MD,FACP – University of Alabama at Birmingham
    Crystal arthropathies
  • Monday, Nov 18th
    10:00 AM – 11:30 AM Eastern Time
    18M15: Not So Crystal Clear: The Changing Landscape of Crystalline Arthritis Diagnosis
    Location: Room 103AB
    Moderator: Naomi Schlesinger, MD – University of Utah
    Moderator: Michael Toprover, MD – New York University Langone Health
    Crystal arthropathies
     CME 1.5 hours
  • Monday, Nov 18th
    10:00 AM – 10:30 AM Eastern Time
    Novel Imaging Techniques in Crystal-Induced Arthritis
    Location: Room 103AB
    Speaker: Fabio Becce, MD – Lausanne University Hospital (CHUV)
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 11:00 AM Eastern Time
    Emerging Technologies in Synovial Fluid Analysis
    Location: Room 103AB
    Speaker: Sara Tedeschi, MD;MPH – Brigham and Women's Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    11:00 AM – 11:30 AM Eastern Time
    Evidence-Based Paradigm Shift in the Diagnosis and Classification of Crystal Arthritis
    Location: Room 103AB
    Speaker: Nicola Dalbeth, MD – University of Auckland
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III
    Crystal arthropathies
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2005: Impact of Anti-drug Antibodies on the Efficacy of SEL-212 in Patients with Chronic Gout Refractory to Conventional Therapy
    Abstract Poster Presenter: Puja Khanna, MD, MPH (she/her/hers) – University of Michigan
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2006: Gout Flares After Stopping Anti-inflammatory Prophylaxis During the Early Phases of Urate-Lowering Therapy
    Abstract Poster Presenter: Lisa Stamp, PhD,FRACP – University of Otago, Christchurch
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2007: Relationship Between Gout Flare Burden and Patient-Reported Outcome Following Allopurinol Initiation
    Abstract Poster Presenter: Lisa Stamp, PhD,FRACP – University of Otago, Christchurch
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2008: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Dose of ABP-671 in Participants with Chronic Kidney Disease (CKD)
    Abstract Poster Presenter: Ullrich Schwertschlag, MD,PhD (he/him/his) – AtomBioScience
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2009: Risk of Incident Gout and Cardiovascular Events Within 120 Days of Incident Gout with the Use of Insulin Glargine, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Veterans with Type 2 Diabetes
    Abstract Poster Presenter: Naomi Schlesinger, MD – University of Utah
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2010: The Influence of Treat-to-target Urate Lowering Therapy and Anti-inflammatory Prophylaxis on Circulating Measures of Inflammation in Gout
    Abstract Poster Presenter: Austin Wheeler, MD – University of Nebraska Medical Center
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2011: The Relationship Between Anti-drug Antibodies, Infusion Reactions, and Loss of Urate-lowering Response in Patients with Uncontrolled Gout Treated with Pegloticase
    Abstract Poster Presenter: Brian LaMoreaux, MD, MS – Amgen, Inc.
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2012: Safety, Tolerability and Efficacy of Pegloticase Administered with a Shorter Infusion Duration in Subjects with Uncontrolled Gout Receiving Methotrexate: Primary Findings of the AGILE Open-label Trial
    Abstract Poster Presenter: Brian LaMoreaux, MD;MS – Amgen, Inc.
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2013: Elevated Serum Allantoin and Allantoin/uric Acid Ratio as Indicators of Oxidative Stress in Severe Gout and Cardiovascular Comorbidities
    Abstract Poster Presenter: Jakub Závada, MD,PhD – Institute of Rheumatology, Prague
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2014: Effect of a Whole Food Plant-Based Diet in Patients with Gout: A Pilot Randomized Controlled Trial
    Abstract Poster Presenter: Carlijn Wagenaar, MD – Reade Rheumatology Center
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2015: Health-Related Quality of Life in Patients with Gout Receiving Treat-to-Target Urate-Lowering Therapy
    Abstract Poster Presenter: Austin Barry, MD – University of Nebraska Medical Center
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2016: Treat to Target in Gout Yields Superior Outcomes Compared to Treat to Avoid Symptoms Approach (results from the Gout TrEatment Strategy Overture Trial)
    Abstract Poster Presenter: Anusha Moses, MSc (she/her/hers) – University of Twente
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2017: Race, Ethnicity, and Rheumatology Care Predict Long-term Urate-Lowering Treatment Persistence Following a Treat-to-Target Intervention in a Large, Multicenter Randomized Trial
    Abstract Poster Presenter: Samantha Kohn, MD – University of Nebraska Medical Center
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2018: Non-adherence to Urate Lowering Therapy in Gout After 5 Years Is Related to Poor Outcomes – Results from the NOR-Gout Study
    Abstract Poster Presenter: Till Uhlig, MD,PhD (he/him/his) – Diakonhjemmet Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2019: Safety and Efficacy of SEL-212 in the US and ex-US Subgroups: Results from the Phase 3 DISSOLVE Studies
    Abstract Poster Presenter: Michael Pillinger, MD – New York University Grossman School of Medicine
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2020: Prediction of the Response of Patients with Chronic Uncontrolled Gout to Pegloticase
    Abstract Poster Presenter: Peter E. Lipsky, MD – AMPEL BioSolutions
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2021: The Dual Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Nephrolithiasis and Gout Flares Among Gout Patients with Type 2 Diabetes: New User, Active Comparator Target Trial Emulation Studies
    Abstract Poster Presenter: Natalie McCormick, PhD (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2022: Could Initiation of Sodium Glucose Co-Transporter-2 Inhibitors Reduce the Need for Conventional Urate-Lowering Therapy and Flare Medications in Patients with Gout?Population-Based Target Trial Emulation Studies
    Abstract Poster Presenter: Natalie McCormick, PhD (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2023: A PEGylated Mammalian Uricase Suitable for Intramuscular Administration to Patients with Refractory Chronic Gout
    Abstract Poster Presenter: Frank Fan, n/a – Chongqing PegBio Biopharm Co.,Ltd.
    Crystal arthropathies
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2024: Serum Urate Change Among Patients with Gout Treated with Anti-Hypertensive Medications: A Comparative Effectiveness Analysis
    Abstract Poster Presenter: Chio Yokose, MD,MSc (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    1:00 PM – 2:30 PM Eastern Time
    18M54: Abstracts: Metabolic & Crystal Arthropathies
    Location: Room 145AB
    Abstract Moderator: Naomi Schlesinger, MD – University of Utah
    Abstract Moderator: Michael Toprover, MD – New York University Langone Health
    Crystal arthropathies
     CME 0 hours
  • Monday, Nov 18th
    1:00 PM – 1:15 PM Eastern Time
    2557: The Relation of Colchicine to Knee/hip Replacement Among People with Gout in a Population-based Cohort Study
    Location: Room 145AB
    Presenting Author: Tuhina Neogi, MD;PhD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
    Crystal arthropathies
  • Monday, Nov 18th
    1:15 PM – 1:30 PM Eastern Time
    2558: Development of Non-genetic Risk Stratification Model of Severe Allopurinol Hypersensitivity Syndrome, a Multicenter Study in Thailand
    Location: Room 145AB
    Presenting Author: Patapong Towiwat, MD – Naresuan University
    Crystal arthropathies
  • Monday, Nov 18th
    1:30 PM – 1:45 PM Eastern Time
    2559: Relationship Between Serum Urate and Changes in Dual Energy Computed Tomography MSU Crystal Volume over One Year in People with Gout: An Individual Participant Data Analysis
    Location: Room 145AB
    Presenting Author: Nicola Dalbeth, MD – University of Auckland
    Crystal arthropathies
  • Monday, Nov 18th
    1:45 PM – 2:00 PM Eastern Time
    2560: Continuous Reduction in Ultrasound Detected Crystal Depositions over 5 Years Follow-up: Results from the NOR-Gout Study
    Location: Room 145AB
    Presenting Author: Till Uhlig, MD,PhD (he/him/his) – Diakonhjemmet Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    2:00 PM – 2:15 PM Eastern Time
    2561: Circulating Proteomic Profiles and Incident Gout Risk: Prospective Cohort Study of >48,000 Men and Women
    Location: Room 145AB
    Presenting Author: Natalie McCormick, PhD (she/her/hers) – Massachusetts General Hospital
    Crystal arthropathies
  • Monday, Nov 18th
    2:15 PM – 2:30 PM Eastern Time
    2562: Efficacy and Safety of Tocilizumab in the Treatment of Chronic Inflammatory Forms of CPPD: Retrospective Study of 55 Cases
    Location: Room 145AB
    Presenting Author: Augustin Latourte, MD,PhD – AP-HP
    Crystal arthropathies
  • Monday, Nov 18th
    3:00 PM – 4:30 PM Eastern Time
    18M44: Gout, Gout, Get Ready for a Bout: Here Come New Mechanisms to Knock You Out
    Location: Room 143ABC
    Moderator: Naomi Schlesinger, MD – University of Utah
    Moderator: Michael Pillinger, MD – New York University Grossman School of Medicine
    Crystal arthropathies
     CME 1.5 hours
  • Monday, Nov 18th
    3:00 PM – 3:30 PM Eastern Time
    Neutrophil Extracellular Trap-Borne Elastase Prevents Inflammatory Relapse in Gout
    Location: Room 143ABC
    Speaker: Martin Herrmann, n/a – Friedrich-Alexander Universität Erlangen-Nürnberg
    Crystal arthropathies
  • Monday, Nov 18th
    3:30 PM – 4:00 PM Eastern Time
    Novel Biomarkers for Gout
    Location: Room 143ABC
    Speaker: Hang-Korng Ea, MD,PhD – Université Paris Cité, INSERM UMR 1132 BIOSCAR
    Crystal arthropathies
  • Monday, Nov 18th
    4:00 PM – 4:30 PM Eastern Time
    Emerging Targets in Gout
    Location: Room 143ABC
    Speaker: Khaled Elsaid, PhD, PharmD – Chapman University
    Crystal arthropathies